| HOME >> BIOLOGY >> TECHNOLOGY |
Vaccines 83
Live attenuated influenza vaccine vs. inactivated vaccine 84
Vaccines for H1N1 influenza 84
Vaccines in development 85
Cell culture-derived influenza vaccines 85
DNA vaccines for avian influenza 86
Epitope-based vaccines for influenza 86
Gene-based vaccines for influenza 87
MAbs for passive immunization against avian influenza 87
M2e-based human influenza A vaccine. 87
MF-59 as adjuvant for influenza vaccine 88
Pre-pandemic split antigen H5N1 vaccine 88
Recombinant hemagglutinin influenza vaccine 89
Synthetic avian influenza vaccine 89
Virus-like particles as influenza vaccines 90
Current status of influenza vaccines and limitations 91
Current recommendations for influenza vaccination 91
Limitations of current influenza vaccines 91
Needs of influenza vaccines 92
Problems with demand and supply of influenza vaccines 93
Problems with access to virus samples 93
FluVac project for development of pandemic influenza vaccine 94
Influenza vaccines for multiple strains of the disease 94
Current status of vaccine preparedness against seasonal influenza 94
Current status of vaccine preparedness against H5N1 95
RNAi-based approaches 95
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |